Ovid Therapeutics
OVID
OVID
48 hedge funds and large institutions have $49.8M invested in Ovid Therapeutics in 2018 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 26 increasing their positions, 7 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
-1
Holders Change %
-2.04%
% of All Funds
1.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
26
Reduced
7
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
+$2.09M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$598K |
| 3 |
Jennison Associates
New York
|
+$514K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$470K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$420K |
Top Sellers
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$6.64M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$2.21M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.78M |
| 4 |
CC
Casdin Capital
New York
|
-$1.58M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$1.07M |
